AstraZeneca buys partner Omniose for bacterial vaccine technology
AstraZeneca has acquired St. Louis-based biotech Omniose to add its proprietary bioconjugation platform to the company's infectious disease vaccine pipeline.
48 trends tracked about this subject — the full history, oldest to newest below.
AstraZeneca has acquired St. Louis-based biotech Omniose to add its proprietary bioconjugation platform to the company's infectious disease vaccine pipeline.
Recent coverage highlights an experimental pancreatic cancer vaccine showing promise in a clinical trial.
Mahoning County Public Health confirmed Ohio's first measles case in Mahoning County, a resident who tested positive, as officials track exposures and warn of symptoms.
Recent reporting examines the medical decision of receiving a shingles vaccine at a younger age.
An experimental mRNA vaccine targeting KRAS mutations triggered immune responses in 99% of pancreatic cancer patients in recent Phase 2 study results.
A human challenge trial shows dengue can re‑emerge in vaccinated individuals, spotlighting the role of pre‑existing immunity.
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Clinical trials for the new Tumaini Ebola vaccine have begun in Bunia as health authorities grapple with a rising death toll.
4 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Moderna stock extends recent market losses following the release of trial data concerning a novel mRNA melanoma vaccine.
12 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Health experts are advising an immediate start to flu vaccinations as Florida's flu season begins this week and vaccine options expand.
9 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
A growing measles outbreak in Northeast Ohio has spread to additional counties, prompting urgent vaccine clinics and public health warnings.
4 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
2 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Recent coverage examines dementia prevention strategies, linking specific vaccines, hormone therapies, and physical exercise routines to risk outcomes.
New research and targeted regional campaigns are expanding the perceived benefits and accessibility of the HPV vaccine beyond cervical cancer prevention.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
3 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Moderna and Merck's mRNA melanoma vaccine is drawing significant attention as a potential game changer according to recent coverage.
2 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Moderna and Merck report success in a late-stage melanoma trial for their personalized mRNA cancer vaccine.
Health authorities and global outlets report ongoing rollout discussions and upcoming trials for Ebola vaccines in the DRC.
9 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
5 news sources are covering this Business story right now — PULSE is tracking how fast it spreads.
Moderna launches its first human trial for a new mRNA Ebola vaccine targeting the specific strain spreading in the Democratic Republic of Congo.
A mutant KRAS vaccine yields early positive results in its first human clinical trial for high-risk pancreatic cancer patients.
India has approved its first dengue vaccine as South Asian cases surge, introducing Takeda's TAK-003 to an at-risk population.
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
A Johns Hopkins-developed KRAS vaccine has demonstrated safety and durable immune responses in a trial focused on preventing pancreatic cancer in high-risk individuals.
Oxford launches the first human trial for a Bundibugyo Ebola vaccine as an active outbreak continues.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
6 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
1 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
13 news sources are covering this Health story right now — PULSE is tracking how fast it spreads.
Brazil has suspended the use of the Butantan-DV vaccine following reports of two deaths and several adverse reactions.
Clinical trials are underway for the world’s first universal coronavirus vaccine created entirely through artificial intelligence.
Global research efforts accelerate as scientists scramble to test new vaccines and treatments in response to a widening Ebola outbreak.
AI-designed vaccine enters human trials, marking a potential leap in pandemic preparedness